The global sleep apnea devices market was valued at US$ 7 Bn in 2020 and is expected to surpass around US$ 14.7 Bn by 2030 with a CAGR of 8.5% from 2021 to 2030.
The global sleep apnea devices market was valued at US$ 7 Bn in 2020 and is expected to surpass around US$ 14.7 Bn by 2030 with a CAGR of 8.5% from 2021 to 2030.
Several multinational companies and emerging players in the sleep apnea devices market have already started re-evaluating their supply chains and in the process of shuffling their business operations to reduce concentration in a handful of countries during the ongoing COVID-19 pandemic. However, lack of insurance coverage for OSA and its related therapeutic & diagnostic machines and devices are affecting market growth in developing economies such as India. Hence, med-tech companies in the sleep apnea devices market should invest in marketing and advertising to increase the acceptance of these devices among patients. Such trends will encourage insurance companies to provide health coverage for sleep apnea and related comorbidities including OSA.
Get the sample copy of report@ https://qyresearchmedical.com/sample/112083
Collaborative Agreements Help Innovate in Sleep Apnea Devices
Key players in the global sleep apnea devices market are engaged in meeting regulatory approvals, launching technologically advanced products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the sleep apnea devices market. Business expansion strategies adopted by players operating in the global sleep apnea devices market are innovating in 3D printed parts used to convert BiPAP (Bilevel Positive Airway Pressure) machines, generally used to treat sleep apnea or COPD, into ventilators.
Companies are entering into collaboration agreements to bring obstructive sleep apnea (OSA) treatment products directly to customers through sleep clinics in the U.S. They are introducing customizable oral appliance therapy devices, which hold potentials as an alternative to CPAP (continuous positive airway pressure) therapy in the U.S.
eHealth Holds Potentials for Device Sales Post COVID-19 Pandemic
Telehealth and eHealth mobile apps are anticipated to transform the sleep apnea devices market post the COVID-19 pandemic period. However, participants in the market are addressing disruption for sales since elective medical procedures have been postponed indefinitely. Hence, companies are taking data-driven decisions to map volatile demand trends for sleep apnea devices.
Domestic and global companies are in the midst of rapid shift in supply chain planning, operations, and inventory management to address the impact of the pandemic. Nevertheless, companies are taking advantage of government stimulus packages to stay financially afloat. The demand for sleep apnea devices is projected to increase at a sluggish pace, due to the lockdown being enforced in most countries.
Ask here for more details@ https://qyresearchmedical.com/submit-inquiry/112083
Lack of Insurance Coverage for Sleep Apnea Devices Hampers Market Growth
The most common treatment option for people with sleep apnea are CPAP devices. These machines are available in various sizes and styles. The price varies depending on the brand, type, and features. However, a CPAP machine can cost anywhere from US$ 250 to US$ 1,000 or more at retail. This is hampering market growth. Hence, companies should partner with experts to innovate in devices that are affordable.
On the other hand, in emerging markets such as India, the lack of medical coverage provided by public or private insurance companies tends to restrain the market growth in the region. Dearth of awareness about obstructive sleep apnea in emerging countries is expected to affect market growth during the forecast period. Hence, companies should focus on marketing sleep apnea devices to increase its acceptance, which, in turn, will encourage insurance companies to provide coverage for health issues pertaining to the OSA.
High Prevalence of Sleep Apnea Patients Contributes to Market Growth
Sleep disorders, including sleep apnea, have emerged as a major public health concern in the U.S. Sleep apnea affects an estimated 22 million people in the U.S., with 80% of moderate and severe obstructive sleep apnea cases going undiagnosed. This is fueling the need of advertising on sleep apnea devices to make people aware about the serious health risks of OSA.
OSA, which accounts for the majority of cases, can lead to high blood pressure, chronic heart failure, atrial fibrillation, stroke, and other cardiovascular problems if left untreated. It is linked to type 2 diabetes and depression, and is a factor in a number of traffic accidents and accidents involving heavy machinery due to the persistent drowsiness experienced by many OSA patients before the disease is diagnosed and treated. Thus, med-tech companies in the sleep apnea devices market should capitalize on this opportunity to bolster manufacturing capabilities to increase the availability of machines.
Health Risks of OSA Fueling Demand for Sleep Apnea Devices
Obstructive sleep apnea is a prevalent disease wherein people continuously halt or reduce their breathing while sleeping. This leads to restless, fragmented sleep, which could cause symptoms such as morning headaches and daytime lethargy.
OSA affects people of all ages; however, it is more common in people over the age of 60. The precise incidence is unknown; however, it is thought to be between 2% and 14%. Obstructive sleep apnea is linked to a number of health problems, including hypertension, coronary artery disease, cardiac arrhythmias, and depression. Obesity, one of the major sleep apnea risk factors, is on the rise, and contributes to the increase in prevalence of sleep apnea. Such trends are translating into revenue opportunities for med-tech companies in the sleep apnea devices market.
Sleep Apnea Devices Market: Overview
The global sleep apnea devices market for the historical period 2017–2030 and forecast period 2021–2030, rise in demand for home sleep apnea tests (HSATs) is projected to drive the global sleep apnea devices market during the forecast period
Rise in Prevalence of Obstructive Sleep Apnea Disorder (OSA): Key Driver
Obstructive sleep apnea is a prevalent disease, in which people continuously halt or reduce their breathing while sleeping. This leads to restless, fragmented sleep, which could cause symptoms such as morning headaches and daytime lethargy.
Obstructive sleep apnea affects people of all ages; however, it is more common in people over the age of 60. The precise incidence is unknown; however, it is thought to be between 2% and 14%. Obstructive sleep apnea is linked to a number of health problems including hypertension, coronary artery disease, cardiac arrhythmias, and depression.
Obesity, one of the major sleep apnea risk factors, is on the rise, and contributes to the increase in prevalence of sleep apnea
Large Number of Undiagnosed Sleep Apnea Patients
Sleep disorders, including sleep apnea, have emerged as a major public health concern in the U.S. Sleep apnea affects an estimated 22 million people in the U.S., with 80 percent of moderate and severe obstructive sleep apnea cases going undiagnosed.
OSA, which accounts for the majority of cases, can lead to high blood pressure, chronic heart failure, atrial fibrillation, stroke, and other cardiovascular problems if left untreated. It is linked to type 2 diabetes and depression, and is a factor in a number of traffic accidents and accidents involving heavy machinery due to the persistent drowsiness experienced by many OSA patients before the disease is recognized and treated.
High Cost of Sleep Apnea Devices
The most common treatment option for people with sleep apnea is continuous positive airway pressure (CPAP) device
These machines are available in various sizes and styles. The price varies depending on the brand, type, and features. A CPAP machine can cost anywhere from US$ 250 to US$ 1,000 or more at retail.
Similarly, in emerging markets such as India, the lack of medical coverage provided by public or private insurance companies restrains the market in the region
Lack of awareness about obstructive sleep apnea (OSA) in emerging countries is expected to hamper market growth during the forecast period
Sleep Apnea Devices Market: Competition Landscape
This report profiles major players in the global sleep apnea devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global sleep apnea devices market is highly fragmented, with the presence of a number of international as well as regional players
Leading players operating in the global sleep apnea devices market are
- ResMed, Inc.
- BMC Medical Co., Ltd.
- Braebon Medical Corporation
- Compumedics Limited
- Devilbiss Healthcare LLC
- Fisher &Paykel Healthcare Limited
- Koninklijke Philips N.V.
- Löwenstein Group
- Oventus Medical
- Panthera Dental
- SomnoMed Limited
- Whole You (Subsidiary of Mitsui Chemicals, Inc.), among others
Key Questions Answered in Global Sleep Apnea Devices Market Report
- What is the scope of growth of product companies in the global sleep apnea devices market?
- What will be the Y-o-Y growth of the global sleep apnea devices market between 2017 and 2028?
- What is the influence of changing trends in technologies on the global sleep apnea devices market?
- Will North America be the most profitable market for sleep apnea device providers?
- Which factors are anticipated to hamper the growth of the global sleep apnea devices market during the forecast period?
- Which are the leading companies in the global sleep apnea devices market?
Sleep Apnea Devices Market – Segmentation
Diagnostic Device
- Actigraphy Systems
- Polysomnography (PSG) Devices
- Respiratory Polygraph
- Single-channel Screening Devices (Pulse Oximeters)
Therapeutic Device
- Airway Clearance Systems
- Adaptive Servo-ventilation (ASV)
- Positive Airway Pressure (PAP) Devices
- Oral Appliances
- Oxygen Devices
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/112083/
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/